Skip to main content
. 2014 Jun 1;24(6):975–986. doi: 10.1089/thy.2013.0470

Table 4.

Hypothetical Outcomes of Thyroid Cancer Evaluation in Model of Obese Patients

Strategy Average cost per patient Incremental cost (% incremental cost)
No screening $210.73
Universal US screening $434.10 +$223.37 (106%)
Risk-based screening $166.72 −$44.01 (−21%)